| |
Jack Barbut joined NovImmune as Chief Executive Officer since 2001. He is the former President
and Chief Executive Officer of Synarc Inc, San Francisco, (1998-2000)
with more than 20 years of professional experience in clinical trials
management and drug development. Prior to joining Synarc, Jack Barbut
was the founder, Vice-Chairman and President of Clinical Services of
Chrysalis International, Inc., (1981-1998) a publicly (NASDAQ) traded
global full service, Contract Research Organization (CRO). A Swiss citizen, Jack Barbut holds a MS in Electrical
Engineering and a ScD in Systems Engineering from the EPFL in Lausanne,
Switzerland. |
|